Professional Documents
Culture Documents
Levothyroxine
Levothyroxine, also known as L-thyroxine, is a
Levothyroxine
manufactured form of the thyroid hormone thyroxine
(T4).[2][5] It is used to treat thyroid hormone deficiency,
including the severe form known as myxedema coma.[2] It
may also be used to treat and prevent certain types of
thyroid tumors.[2] It is not indicated for weight loss.[2]
Levothyroxine is taken by mouth or given by injection into
a vein.[2] Maximum effect from a specific dose can take up
to six weeks to occur.[2]
History ltype=all&query=Levothyrox
Society and culture ine)
Economics Pregnancy AU: A [1]
Available forms category
US: N (Not classified yet) [1]
References
Routes of By mouth, intravenous
External links administration
ATC code H03AA01 (WHO (https://ww
w.whocc.no/atc_ddd_inde
Medical use x/?code=H03AA01))
Levothyroxine is typically used to treat Legal status
hypothyroidism, [10] and is the treatment of choice for Legal status US: ℞-only
people with hypothyroidism,[11] who often require lifelong
thyroid hormone therapy.[12] Pharmacokinetic data
Bioavailability 40-80%[2]
It may also be used to treat goiter via its ability to lower Metabolism mainly in liver, kidneys,
thyroid-stimulating hormone (TSH), a hormone that is
brain and muscles
considered goiter-inducing.[13][14] Levothyroxine is also
Elimination ca. 7 days (in
used as interventional therapy in people with nodular half-life
thyroid disease or thyroid cancer to suppress TSH hyperthyroidism 3–4 days,
secretion.[15] A subset of people with hypothyroidism in hypothyroidism 9–
treated with an appropriate dose of levothyroxine will 10 days)
describe continuing symptoms despite TSH levels in the Excretion feces and urine
normal range.[12] In these people, further laboratory and Identifiers
clinical evaluation is warranted as they may have another
IUPAC name
cause for their symptoms.[12] Furthermore, it is important
CAS Number 51-48-9 (http://www.commo
to review their medications and possible dietary
supplements as several medications can affect thyroid nchemistry.org/ChemicalDe
hormone levels.[12] tail.aspx?ref=51-48-9)
6106-07-6 (http://www.com
Levothyroxine is also used to treat subclinical monchemistry.org/Chemical
hypothyroidism which is defined by an elevated TSH level Detail.aspx?ref=6106-07-6
and a normal-range free T4 level without symptoms.[12] &title=) (levothyroxine
Such people may be asymptomatic[12] and whether they sodium hydrate)
should be treated is controversial.[11] One benefit of PubChem CID 5819 (https://pubchem.ncbi.
treating this population with levothyroxine therapy is nlm.nih.gov/compound/581
preventing development of hypothyroidism.[11] As such, it 9)
is recommended that treatment should be taken into
DrugBank DB00451 (https://www.drug
account for patients with initial TSH levels above
10 mIU/L, people with elevated thyroid peroxidase bank.ca/drugs/DB00451)
antibody titers, people with symptoms of hypothyroidism ChemSpider 5614 (http://www.chemspid
and TSH levels between 5–10 mIU/L, and women who are er.com/Chemical-Structure.
pregnant or want to become pregnant.[11] Oral dosing for 5614.html)
patients with subclinical hypothyroidism is
[16] UNII Q51BO43MG4 (https://fdasi
1 μg/kg/day.
s.nlm.nih.gov/srs/srsdirect.j
It is also used to treat myxedema coma, which is a severe sp?regno=Q51BO43MG4)
form of hypothyroidism characterized by mental status KEGG D08125 (http://www.kegg.j
changes and hypothermia.[12] As it is a medical emergency p/entry/D08125)
with a high mortality rate, it should be treated in the
https://en.wikipedia.org/wiki/Levothyroxine 2/9
22/02/2020 Levothyroxine - Wikipedia
intensive care unit[12] with thyroid hormone replacement ChEBI CHEBI:18332 (https://www.
and aggressive management of individual organ system ebi.ac.uk/chebi/searchId.d
complications.[11] o?chebiId=CHEBI:18332)
ChEMBL ChEMBL1624 (https://www.
Dosages vary according to the age groups and the
ebi.ac.uk/chembldb/index.p
individual condition of the person, body weight and
hp/compound/inspect/ChE
compliance to the medication and diet. Other predictors of
MBL1624)
the required dosage are sex, BMI, deiodinase activity
(SPINA-GD) and etiology of hypothyroidism.[17] Annual CompTox DTXSID8023214 (https://co
Dashboard (EPA)
or semiannual clinical evaluations and TSH monitoring are mptox.epa.gov/dashboard/
appropriate after dosing has been established.[18] DTXSID8023214)
Levothyroxine is taken on an empty stomach ECHA InfoCard 100.000.093 (https://echa.e
approximately half an hour to an hour before meals.[19] As uropa.eu/substance-inform
such, thyroid replacement therapy is usually taken ation/-/substanceinfo/100.0
30 minutes prior to eating in the morning.[12] For patients 00.093)
with trouble taking levothyroxine in the morning, bedtime
Chemical and physical data
dosing is effective as well.[12] A 2015 study showed
greater efficacy of levothyroxine when taken at Formula C15H11I4NO4
bedtime.[20] Doses of levothyroxine that normalize serum Molar mass 776.874 g·mol−1
TSH may not normalize abnormal levels of LDL 3D model Interactive image (https://ch
cholesterol and total cholesterol.[21] (JSmol)
emapps.stolaf.edu/jmol/jmo
Poor compliance in taking the medicine is the most l.php?model=NC%28Cc1c
common cause of elevated TSH levels in people receiving c%28I%29c%28Oc2cc%28
appropriate doses of levothyroxine.[12] I%29c%28O%29c%28I%29
c2%29c%28I%29c1%29
C%28O%29%3DO)
Elderly Melting point 231 to 233 °C (448 to
For older people (over 50 years old) and people with 451 °F) [4]
known or suspected ischemic heart disease, levothyroxine Solubility in Slightly soluble
therapy should not be initiated at the full replacement water (0.105 mg·mL−1 at
dose.[22] Since thyroid hormone increases the heart's 25 °C)[3] mg/mL (20 °C)
oxygen demand by increasing heart rate and contractility,
SMILES
starting at higher doses may cause an acute coronary
syndrome or an abnormal heart rhythm.[12] InChI
https://en.wikipedia.org/wiki/Levothyroxine 3/9
22/02/2020 Levothyroxine - Wikipedia
Thyroid hormone requirements increase during and last throughout pregnancy.[12] As such, it is
recommended that pregnant women increase to nine doses of levothyroxine each week, rather than the usual
seven, as soon as their pregnancy is confirmed.[12] Repeat thyroid function tests should be done five weeks
after the dosage is increased.[12]
While a minimal amount of thyroid hormones are found in breast milk, the amount does not influence infant
plasma thyroid levels.[16] Furthermore, levothyroxine was not found to cause any adverse events to the
infant or mother during breastfeeding.[16] As adequate concentrations of thyroid hormone are required to
maintain normal lactation, it is recommended that appropriate levothyroxine doses be administered during
breastfeeding.[16]
Children
Levothyroxine is safe and effective for children with hypothyroidism; the goal of treatment for children with
hypothyroidism is to reach and preserve normal intellectual and physical development.[22]
Contraindications
Levothyroxine is contraindicated in people with hypersensitivity to levothyroxine sodium or any component
of the formulation, people with acute myocardial infarction, and people with thyrotoxicosis of any
etiology.[16] Levothyroxine is also contraindicated for people with uncorrected adrenal insufficiency, as
thyroid hormones may cause an acute adrenal crisis by increasing the metabolic clearance of
glucocorticoids.[22] For oral tablets, the inability to swallow capsules serves as an additional
contraindication.[16]
Side effects
Adverse events are generally caused by incorrect dosing. Long-term suppression of TSH values below
normal values will frequently cause cardiac side-effects and contribute to decreases in bone mineral density
(low TSH levels are also well known to contribute to osteoporosis).[23]
Too high a dose of levothyroxine causes hyperthyroidism.[19][24][25] Overdose can result in heart
palpitations, abdominal pain, nausea, anxiousness, confusion, agitation, insomnia, weight loss, and increased
appetite.[26][24] Allergic reactions to the drug are characterized by symptoms such as difficulty breathing,
shortness of breath, or swelling of the face and tongue. Acute overdose may cause fever, hypoglycemia,
heart failure, coma, and unrecognized adrenal insufficiency.
Acute massive overdose may be life-threatening; treatment should be symptomatic and supportive. Massive
overdose can be associated with increased sympathetic activity and thus require treatment with beta-
blockers.[19]
Interactions
There are many foods and other substances that can interfere with absorption of thyroxine. Substances that
reduce absorption are aluminium and magnesium containing antacids, simethicone, sucralfate,
cholestyramine, colestipol, and polystyrene sulfonate. Grapefruit juice may delay the absorption of
levothyroxine, but based on a study of 10 healthy people aged 20–30 (8 men, 2 women) it may not have a
significant effect on bioavailability in young adults.[27][28] A study of eight women suggested that coffee
may interfere with the intestinal absorption of levothyroxine, though at a level less than eating bran.[29]
https://en.wikipedia.org/wiki/Levothyroxine 4/9
22/02/2020 Levothyroxine - Wikipedia
Certain other substances can cause adverse effects that may be severe. Combination of levothyroxine with
ketamine may cause hypertension and tachycardia;[30] and tricyclic and tetracyclic antidepressants increase
its toxicity. On the other hand, lithium can cause hyperthyroidism (but most often hypothyroidism) by
affecting iodine metabolism of the thyroid itself and thus inhibits synthetic levothyroxine as well.[31] Soy,
cottonseed meal, walnuts, fiber, calcium supplements and iron supplements can also adversely affect
absorption.[27] A study found that cow's milk reduces levothyroxine absorption.[32]
Mechanism of action
Levothyroxine is a synthetic form of thyroxine (T4), an endogenous hormone secreted by the thyroid gland,
which is converted to its active metabolite, L-triiodothyronine (T3).[22] T4 and T3 bind to thyroid receptor
proteins in the cell nucleus and cause metabolic effects through the control of DNA transcription and protein
synthesis.[22] Like its naturally secreted counterpart, levothyroxine is a chiral compound in the L-form.
Pharmacokinetics
Absorption of orally administered levothyroxine from the gastrointestinal tract ranges from 40 to 80%, with
the majority of the drug absorbed from the jejunum and upper ileum.[22] Levothyroxine absorption is
increased by fasting and decreased in certain malabsorption syndromes, by certain foods, and with age. The
bioavailability of the drug is decreased by dietary fiber.[22]
Greater than 99% of circulating thyroid hormones are bound to plasma proteins including thyroxine-binding
globulin, transthyretin (previously called 'thyroxine-binding prealbumin'), and albumin.[16] Only free
hormone is metabolically active.[16]
The primary pathway of thyroid hormone metabolism is through sequential deiodination.[22] The liver is the
main site of T4 deiodination, and along with the kidneys are responsible for about 80% of circulating T3.[33]
In addition to deiodination, thyroid hormones are also excreted through the kidneys and metabolized
through conjugation and glucuronidation and excreted directly into the bile and the gut where they undergo
enterohepatic recirculation.[16]
Half-life elimination is 6–7 days for people with normal lab results; 9–10 days for people with
hypothyroidism; 3–4 days for people with hyperthyroidism.[16] Thyroid hormones are primarily eliminated
by the kidneys (approximately 80%), with urinary excretion decreasing with age.[16] The remaining 20% of
T4 eliminated in the stool.[16]
History
Thyroxine was first isolated in pure form in 1914 at the Mayo Clinic by Edward Calvin Kendall from
extracts of hog thyroid glands.[34] The hormone was synthesized in 1927 by British chemists Charles Robert
Harington and George Barger.
Economics
https://en.wikipedia.org/wiki/Levothyroxine 5/9
22/02/2020 Levothyroxine - Wikipedia
As of 2011, levothyroxine was the second most commonly prescribed medication in the U.S.,[35] with
23.8 million prescriptions filled each year.[36]
In 2016, it became the most commonly prescribed medication in the U.S., with more than 114 million
prescriptions.[9]
Available forms
Levothyroxine for systemic administration is available as an oral tablet, an intramuscular injection, and as a
solution for intravenous infusion.[16] Furthermore, levothyroxine is available as both brand-name and
generic products.[12] While the FDA approved the use of generic levothyroxine for brand-name
levothyroxine in 2004, the decision was met with disagreement by several medical associations.[12] The
American Association of Clinical Endocrinologists (AACE), the Endocrine Society, and the American
Thyroid Association did not agree with the FDA that brand-name and generic formulations of levothyroxine
were bioequivalent.[12] As such, it was recommended that people be started and kept on either brand-name
or generic levothyroxine formulations and not changed back and forth from one to the other.[12] For people
who do switch products, it is recommended that their TSH and free T4 levels be tested after six weeks to
check that they are within normal range.[12]
Common brand names include Eltroxin, Euthyrox, Eutirox, Letrox, Levaxin, Lévothyrox, Levoxyl, L-
thyroxine, Thyrax, and Thyrax Duotab in Europe; Thyrox, Thyronorm in South Asia; Unithroid, Eutirox,
Synthroid, and Tirosint in North and South America; and Thyrin and Thyrolar in Bangladesh. There are also
numerous generic versions.
The related drug dextrothyroxine (D-thyroxine) was used in the past as a treatment for hypercholesterolemia
(elevated cholesterol levels) but was withdrawn due to cardiac side effects.
References
1. "Levothyroxine Use During Pregnancy" (https://www.drugs.com/pregnancy/levothyroxine.html).
Drugs.com. 31 July 2019. Retrieved 22 February 2020.
2. "Levothyroxine Sodium" (https://www.drugs.com/monograph/levothyroxine-sodium.html). The
American Society of Health-System Pharmacists. Archived (https://web.archive.org/web/20161
221013136/https://www.drugs.com/monograph/levothyroxine-sodium.html) from the original on
21 December 2016. Retrieved 8 December 2016.
3. DrugBank DB00451 (https://www.drugbank.ca/drugs/DB00451)
4. Harington CR (1926). "Chemistry of Thyroxine: Constitution and Synthesis of Desiodo-
Thyroxine" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1251714). The Biochemical
Journal. 20 (2): 300–13. doi:10.1042/bj0200300 (https://doi.org/10.1042%2Fbj0200300).
PMC 1251714 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1251714). PMID 16743659 (htt
ps://pubmed.ncbi.nlm.nih.gov/16743659).
5. King, Tekoa L.; Brucker, Mary C. (2010). Pharmacology for Women's Health (https://books.goo
gle.com/books?id=E9qVyrNPsBkC&pg=PA544). Jones & Bartlett Publishers. p. 544.
ISBN 9781449658007. Archived (https://web.archive.org/web/20170910234123/https://books.g
oogle.com/books?id=E9qVyrNPsBkC&pg=PA544) from the original on 10 September 2017.
6. World Health Organization (2019). World Health Organization model list of essential
medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771 (https://hdl.h
andle.net/10665%2F325771). WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
7. "Levothyroxine" (http://mshpriceguide.org/en/single-drug-information/?DMFId=466&searchYear
=2014). International Drug Price Indicator Guide. Retrieved 8 December 2016.
https://en.wikipedia.org/wiki/Levothyroxine 6/9
22/02/2020 Levothyroxine - Wikipedia
8. Hamilton, Richart (2015). Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition.
Jones & Bartlett Learning. p. 223. ISBN 9781284057560.
9. "The Top 300 of 2019" (https://clincalc.com/DrugStats/Top300Drugs.aspx). clincalc.com.
Retrieved 22 December 2018.
10. Vaidya B, Pearce SH (July 2008). "Management of hypothyroidism in adults" (https://semantics
cholar.org/paper/6a596718ffb9c5b8593d71427ba841d5be6fbe54). BMJ. 337: a801.
doi:10.1136/bmj.a801 (https://doi.org/10.1136%2Fbmj.a801). PMID 18662921 (https://pubmed.
ncbi.nlm.nih.gov/18662921).
11. Roberts, Caroline GP; Ladenson, Paul W (2004). "Hypothyroidism". The Lancet. 363 (9411):
793–803. doi:10.1016/S0140-6736(04)15696-1 (https://doi.org/10.1016%2FS0140-6736%280
4%2915696-1). PMID 15016491 (https://pubmed.ncbi.nlm.nih.gov/15016491).
12. Gaitonde DY, Rowley KD, Sweeney LB (August 2012). "Hypothyroidism: an update" (https://w
ww.aafp.org/afp/2012/0801/p244.html). American Family Physician. 86 (3): 244–51.
PMID 22962987 (https://pubmed.ncbi.nlm.nih.gov/22962987).
13. Svensson J, Ericsson UB, Nilsson P, Olsson C, Jonsson B, Lindberg B, Ivarsson SA (May
2006). "Levothyroxine treatment reduces thyroid size in children and adolescents with chronic
autoimmune thyroiditis" (http://jcem.endojournals.org/cgi/pmidlookup?view=long&pmid=16507
633). The Journal of Clinical Endocrinology and Metabolism. 91 (5): 1729–34.
doi:10.1210/jc.2005-2400 (https://doi.org/10.1210%2Fjc.2005-2400). PMID 16507633 (https://
pubmed.ncbi.nlm.nih.gov/16507633).
14. Dietlein M, Wegscheider K, Vaupel R, Schmidt M, Schicha H (2007). "Management of
multinodular goiter in Germany (Papillon 2005): do the approaches of thyroid specialists and
primary care practitioners differ?". Nuklearmedizin. Nuclear Medicine. 46 (3): 65–75.
doi:10.1160/nukmed-0068 (https://doi.org/10.1160%2Fnukmed-0068). PMID 17549317 (https://
pubmed.ncbi.nlm.nih.gov/17549317).
15. Mandel SJ, Brent GA, Larsen PR (September 1993). "Levothyroxine therapy in patients with
thyroid disease". Annals of Internal Medicine. 119 (6): 492–502. doi:10.7326/0003-4819-119-6-
199309150-00009 (https://doi.org/10.7326%2F0003-4819-119-6-199309150-00009).
PMID 8357116 (https://pubmed.ncbi.nlm.nih.gov/8357116).
16. "Levothyroxine (Lexi-Drugs)" (http://online.lexi.com/lco/action/doc/retrieve/docid/patch_f/7172).
LexiComp. Archived (https://web.archive.org/web/20140929172946/http://online.lexi.com/lco/a
ction/doc/retrieve/docid/patch_f/7172) from the original on 29 September 2014. Retrieved
20 April 2014.
17. Midgley JE, Larisch R, Dietrich JW, Hoermann R (December 2015). "Variation in the
biochemical response to L-thyroxine therapy and relationship with peripheral thyroid hormone
conversion efficiency" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557078). Endocrine
Connections. 4 (4): 196–205. doi:10.1530/EC-15-0056 (https://doi.org/10.1530%2FEC-15-005
6). PMC 4557078 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557078). PMID 26335522
(https://pubmed.ncbi.nlm.nih.gov/26335522).
18. Hypothyroidism~treatment (https://emedicine.medscape.com/article/122393-treatment) at
eMedicine
19. "Synthroid (Levothyroxine Sodium) Drug Information: Uses, Side Effects, Drug Interactions
and Warnings" (http://www.rxlist.com/synthroid-drug.htm). RxList. Archived (https://web.archiv
e.org/web/20100511145303/http://www.rxlist.com/synthroid-drug.htm) from the original on 11
May 2010. Retrieved 18 July 2010.
20. "Effects of Evening vs Morning Levothyroxine Intake: A Randomized Double-blind Crossover
Trial" (http://archinte.jamanetwork.com/article.aspx?articleid=776486). Archived (https://web.ar
chive.org/web/20150906163348/http://archinte.jamanetwork.com/article.aspx?articleid=77648
6) from the original on 6 September 2015.
21. McAninch EA, Rajan KB, Miller CH, Bianco AC (August 2018). "Systemic Thyroid Hormone
Status During Levothyroxine Therapy In Hypothyroidism: A Systematic Review and Meta-
Analysis" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226605). J. Clin. Endocrinol. Metab.
doi:10.1210/jc.2018-01361 (https://doi.org/10.1210%2Fjc.2018-01361). PMC 6226605 (https://
www.ncbi.nlm.nih.gov/pmc/articles/PMC6226605). PMID 30124904 (https://pubmed.ncbi.nlm.n
ih.gov/30124904).
https://en.wikipedia.org/wiki/Levothyroxine 7/9
22/02/2020 Levothyroxine - Wikipedia
https://en.wikipedia.org/wiki/Levothyroxine 8/9
22/02/2020 Levothyroxine - Wikipedia
36. Moore, Thomas. "Monitoring FDA MedWatch Reports: Signals for Dabigatran and
Metoclopramide" (http://www.ismp.org/quarterwatch/pdfs/2011Q1.pdf) (PDF). QuarterWatch.
Institute for Safe Medication Practices. Archived (https://web.archive.org/web/2013092506490
9/http://ismp.org/quarterwatch/pdfs/2011Q1.pdf) (PDF) from the original on 25 September
2013. Retrieved 20 April 2014.
External links
"Levothyroxine" (https://druginfo.nlm.nih.gov/drugportal/name/levothyroxine). Drug Information
Portal. U.S. National Library of Medicine.
Text is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply. By using
this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia
Foundation, Inc., a non-profit organization.
https://en.wikipedia.org/wiki/Levothyroxine 9/9